HealthQuill Clinical research
Tata Group, a $165 billion Indian conglomerate, is set to build a medical school in the southern technology hub of Bengaluru by partnering with the country’s premier science body, the Indian Institute of Science (IISc).
Drugs Medical Research

India’s Tata Group grants $57.8 million to build medical school in IT capital

Tata Group, a $165 billion Indian conglomerate, is set to build a medical school in the southern technology hub of Bengaluru by partnering.

Read More
China’s WuXi Biologics, a clinical research organization, has granted global rights to US-based Candid Therapeutics to use the company’s synthetic antibody to fight cancer for an upfront payment of $925 million.
Drugs Medical Pharma

WuXi Biologics sells global rights to cancer antibody to Candid for $925m

China’s WuXi Biologics, a clinical research organization, has granted global rights to US-based Candid Therapeutics to use the company’s synthetic antibody to fight.

Read More
Denmark’s Novo Nordisk declared its late-stage experimental once-weekly diabetes drug IcoSema achieved its primary endpoint of proving “non-inferiority” in lowering blood sugar levels.
Drugs Health Medical

Breakthrough treatment may end insulin use in type 2 diabetic patients

HQ Team October 15, 2024: A recent study presented at the United European Gastroenterology Week congress in Vienna unveiled a procedure that could.

Read More
Uric acid may emerge as a potential therapy to treat ischemic stroke after US researchers discovered a new method in studies on animals.
Drugs Health Medical

Danish study reveals half of patients with sepsis die within two years

HQ Team October 15, 2024: Severe sepsis and septic shock are major causes of mortality in intensive care unit (ICU) patients. According to.

Read More